About Waft Pharma Private Limited
Data last updated:
Waft Pharma Private Limited is a private limited company based in Rajamahendravaram, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U33100AP2017PTC106922. Its GSTIN is 37AACCW0957B1ZH (Andhra Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Venkata Subbarao Gidugu and Venkata Ramaiah Tumati.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Rajamahendravaram, Andhra Pradesh.
As per the financials filed for FY 2022, the company reported a revenue of ₹30.37 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.19 Lakh (net margin -10.5%) and EBITDA of -₹3.11 Lakh (EBITDA margin -10.2%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
The company is associated with 1 brand: WAFT Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website waftpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address74 – 2 – 5/1 1st Floor Opposite Niveditha Kishore Public School Addepalli Colony Ava Roa, D, Rajamahendravaram, Andhra Pradesh, India – 533103
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Waft Pharma Private Limited
Waft Pharma operates one associated brand: WAFT Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures a range of pharmaceutical products, including tablets, capsules, syrups, liquids, ointments, and injections. | waftpharma.com |
Competitors & Alternatives of Waft Pharma Private Limited
Brands and companies operating in the same space as Waft Pharma Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Jubilant Life Sciences | Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India | 1978 |
 Akums | CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India | 2004 |
 Nectar Lifesciences | Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India | 1995 |
 Windlas | Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India | 2001 |
 Unither | Contract development and manufacturing organization for proprietary and generic drugs | Paris, France | 1993 |
 Recipharm | Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden | 1995 |
 CoreRx | CDMO with a focus on early phase drug product development | Clearwater, United States | 2006 |
 MedPharm | Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom | 1998 |
Business Activity of Waft Pharma Private Limited
The main business activity of Waft Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Waft Pharma Private Limited
Auditor information for Waft Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Waft Pharma Private Limited
Waft Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Subbarao Gidugu | Director | 21 Oct 2020 | 5 Years 11 Months | Current |
| Venkata Ramaiah Tumati | Director | 31 Mar 2018 | 8 Years 6 Months | Current |
| Surya Chandra Sekhara Rao Samsani | Director | 26 Oct 2017 | 8 Years 11 Months | Current |
| Sai Dileep Viswanadha Also directs: Neura Cube LLP, Doctoevo Healthcare Private Limited | Director | 26 Oct 2017 | 8 Years 11 Months | Current |
| Santhi Sree Tumati | Director | 26 Oct 2017 | 8 Years 11 Months | Current |
Financials of Waft Pharma Private Limited FY 2022 filings available
Waft Pharma Private Limited reported revenue of ₹30.37 Lakh (up 4519% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Waft Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 26% over three years. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Waft Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.11 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.19 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Waft Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -10.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Waft Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Waft Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Waft Pharma Private Limited
Waft Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Waft Pharma Private Limited
Employment history and EPFO contributions of people linked to Waft Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Waft Pharma Private Limited
Waft Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCW0957B1ZH | Andhra Pradesh | Active | 07 Dec 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Waft Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Waft Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Waft Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Waft Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Waft Pharma Private Limited
Frequently Asked Questions about Waft Pharma Private Limited
Waft Pharma is an active private limited company based in Rajamahendravaram, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 October 2017 (9+ years old) and is registered under CIN U33100AP2017PTC106922.
Waft Pharma reported revenue of ₹30.37 Lakh for FY 2022 (up 4519% YoY).
Waft Pharma has 5 current directors:
- Venkata Subbarao Gidugu - Director
- Venkata Ramaiah Tumati - Director
- Surya Chandra Sekhara Rao Samsani - Director
- Sai Dileep Viswanadha - Director
- Santhi Sree Tumati - Director
Waft Pharma reported a net loss of ₹3.19 Lakh (net margin -10.5%) and EBITDA of -₹3.11 Lakh (EBITDA margin -10.2%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Waft Pharma is 26% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Waft Pharma is 37AACCW0957B1ZH, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Waft Pharma is U33100AP2017PTC106922. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Waft Pharma was incorporated on 26 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Vijayawada.
Waft Pharma can be reached through the website waftpharma.com. Its registered office is in Rajamahendravaram, Andhra Pradesh, India.